Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Knowledge Action Change (KAC) is a London-based public health agency focused on the promotion of harm reduction as a key strategy for improving global health. The organization specializes in tobacco harm reduction, drug policy reform, and the regulation of nicotine products, aiming to bridge the gap between scientific research and policy implementation. KAC is widely recognized for its Global State of Tobacco Harm Reduction (GSTHR) project, which provides comprehensive data on the availability and use of safer nicotine alternatives worldwide. Through consultancy, research, and the organization of international forums, KAC advocates for evidence-based policies that minimize the health risks associated with tobacco and drug use. The company also manages educational initiatives, such as the Tobacco Harm Reduction Scholarship Programme, to support emerging researchers in the field.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Knowledge Action Change.